Commenting on Mr. Cuevas' new position with Triage, Michael Henson, Chairman and Co-Founder of Triage, said, "Walter has experience in building technical and commercial organizations, managing medical technology products through the IDE/PMA process and working with investors to finance growth. After spending the past three years developing the only truly percutaneous devices to treat spinal diseases, Triage requires all of these skills as it prepares to launch its spine products on a worldwide basis."
Also commenting on this appointment, Triage President and Chief Operating Officer, Chip Stevens said, "Having a CEO with Walter's experience will enable Triage to grow to the next level. We are extremely fortunate to have him."
Triage has developed its patented CLASP® and TELEPORT® technologies for the treatment of a variety of spine conditions. The Company has just completed a 120-patient clinical study of its Percutaneous Lumbar Stabilization ("PLS") System, and is preparing for a U.S. and European market launch during the first half of 2007. The initial pilot clinical trial for the Triage Percutaneous Dynamic Stabilization ("PDS") System has been completed. Triage is also preparing to launch the PDS System in Europe in 2007. Initial clinical studies show the Triage PDS System may provide superior results compared to other dynamic stabilization devices currently marketed or under clinical investigation. The PDS System is the only truly percutaneous dynamic stabilization system available.
Triage Medical, Inc. is a closely held private company based in Irvine, California. Triage develops and markets products based upon CLASP Technology and TELEPORT Access Technology for a broad range of orthopedic applications. For additional information about Triage, please visit the Company's website at www.triagemed.com.
Contact: Triage Medical, Inc. Tom Brown Vice President Sales and Marketing 949-472-0006
Source: Triage Medical, Inc.
